Defining Severity in Alopecia Areata: Current Perspectives and a Multidimensional Framework

被引:0
作者
Brett A. King
Maryanne M. Senna
Manabu Ohyama
Antonella Tosti
Rodney D. Sinclair
Susan Ball
Justin M. Ko
Marc Glashofer
Rodrigo Pirmez
Jerry Shapiro
机构
[1] Yale School of Medicine,Department of Dermatology
[2] Massachusetts General Hospital and Harvard Medical School,Department of Dermatology
[3] Kyorin University,Department of Dermatology, Faculty of Medicine
[4] University of Miami,Dr. Philip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine
[5] Sinclair Dermatology,Department of Dermatology
[6] Eli Lilly and Company,Centro de Estudos dos Cabelos
[7] Stanford University School of Medicine,The Ronald O. Perelman Department of Dermatology
[8] Schweiger Dermatology Group,undefined
[9] Instituto de Dermatologia Professor Rubem David Azulay,undefined
[10] Santa Casa da Misericórdia do Rio de Janeiro,undefined
[11] New York University Grossman School of Medicine,undefined
来源
Dermatology and Therapy | 2022年 / 12卷
关键词
Alopecia areata; Alopecia totalis; Alopecia universalis; Disease severity; Classification;
D O I
暂无
中图分类号
学科分类号
摘要
Alopecia areata (AA) is an autoimmune disease characterized by nonscarring hair loss. As a clinically heterogeneous disease, various classification systems have evolved for defining its severity. In this high-level review of the literature, we discuss the traditional classification systems for AA severity and their strengths and weaknesses. Most recent classifications have focused on the extent of scalp hair loss as a defining feature, but additional clinical aspects of the disease, including location, pattern, and duration of hair loss as well as impact on the patient’s quality of life, are also relevant. These various components have typically been used unidimensionally to classify patients. We propose a multidimensional framework to define AA severity that incorporates multiple patient- and illness-related domains. Using such a framework, dermatologists may better assess the severity of the disease for the individual patient beyond the extent of hair loss.
引用
收藏
页码:825 / 834
页数:9
相关论文
共 73 条
  • [1] Strazzulla LC(2018)Alopecia areata: disease characteristics, clinical evaluation, and new perspectives on pathogenesis J Am Acad Dermatol 78 1-12
  • [2] Wang EHC(2015)Distinctions between diagnostic and classification criteria? Arthritis Care Res (Hoboken). 67 891-897
  • [3] Avila L(1965)A new classification of alopecia areata Dermatology 131 421-445
  • [4] Lo Sicco K(1998)Reappraisal of Ikeda's classification of alopecia areata: analysis of 356 cases from Chandigarh, India J Dermatol 25 108-111
  • [5] Brinster N(2016)Salt II: a new take on the severity of alopecia tool (salt) for determining percentage scalp hair loss J Am Acad Dermatol 75 1268-1270
  • [6] Christiano AM(2016)Alopecia areata progression index, a scoring system for evaluating overall hair loss activity in alopecia areata patients with pigmented hair: a development and reliability assessment Dermatology 232 143-149
  • [7] Aggarwal R(2020)The alopecia areata investigator global assessment scale: a measure for evaluating clinically meaningful success in clinical trials Br J Dermatol 183 702-709
  • [8] Ringold S(2020)The Alopecia Areata Consensus of Experts (ACE) study: results of an international expert opinion on treatments for alopecia areata J Am Acad Dermatol 83 123-130
  • [9] Khanna D(2020)Eyebrows are important in the treatment of alopecia areata J Investig Dermatol Symp Proc 20 S37-s40
  • [10] Neogi T(2018)Nail involvement in alopecia areata: a questionnaire-based survey on clinical signs, impact on quality of life and review of the literature Acta Derm Venereol 98 212-217